NASDAQ:NMRD Nemaura Medical (NMRD) Stock Price, News & Analysis $0.0001 0.00 (-50.00%) (As of 12/20/2024 10:56 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsSustainabilityTrends About Nemaura Medical Stock (NASDAQ:NMRD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nemaura Medical alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range$0.00▼$0.0352-Week Range$0.00▼$0.25Volume1,000 shsAverage Volume42,979 shsMarket Capitalization$4,035.20P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.Read More… Nemaura Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks27th Percentile Overall ScoreNMRD MarketRank™: Nemaura Medical scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Nemaura Medical. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for NMRD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNemaura Medical does not currently pay a dividend.Dividend GrowthNemaura Medical does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-0.97 Short InterestThere is no current short interest data available for NMRD. News and Social Media4.0 / 5News SentimentN/A News SentimentNemaura Medical has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Nemaura Medical this week, compared to 0 articles on an average week.Search Interest1 people have searched for NMRD on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Nemaura Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nemaura Medical insiders have not sold or bought any company stock.Percentage Held by Insiders40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.41% of the stock of Nemaura Medical is held by institutions.Read more about Nemaura Medical's insider trading history. Receive NMRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address NMRD Stock News HeadlinesContrasting Beauty Health (NASDAQ:SKIN) and Nemaura Medical (NASDAQ:NMRD)December 16, 2024 | americanbankingnews.comNemaura Medical (OTC:NMRD) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.December 22, 2024 | Behind the Markets (Ad)Nemaura Medical Inc (NMRD)May 26, 2024 | investing.comNXNN Nexeon Medsystems IncMay 24, 2024 | seekingalpha.comNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning CallsFebruary 23, 2024 | benzinga.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 22, 2024 | finance.yahoo.comNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finanznachrichten.deSee More Headlines NMRD Stock Analysis - Frequently Asked Questions How have NMRD shares performed this year? Nemaura Medical's stock was trading at $0.2190 at the beginning of the year. Since then, NMRD shares have decreased by 100.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. How were Nemaura Medical's earnings last quarter? Nemaura Medical Inc. (NASDAQ:NMRD) released its earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter. How do I buy shares of Nemaura Medical? Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Nemaura Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA). Company Calendar Last Earnings2/12/2024Today12/22/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NMRD CUSIPN/A CIK1602078 Webnemauramedical.com Phone(646) 416-8000FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3,017.00 Price / Sales1.34 Cash FlowN/A Price / Cash FlowN/A Book Value($0.41) per share Price / Book0.00Miscellaneous Outstanding Shares40,352,000Free Float24,042,000Market Cap$4,035.20 OptionableNo Data Beta0.13 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:NMRD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.